These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20941645)

  • 1. Oxidative stress in the cardiorenal metabolic syndrome.
    Whaley-Connell A; Sowers JR
    Curr Hypertens Rep; 2012 Aug; 14(4):360-5. PubMed ID: 22581415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial Responses to a Standardised Meal in Hypertension: The Mediatory Role of Visceral Fat Mass.
    Louca P; Berry SE; Bermingham K; Franks PW; Wolf J; Spector TD; Valdes AM; Chowienczyk P; Menni C
    Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined-JinQi-JiangTang tablet ameliorates hypertension through activation of FGF21/FGFR1 axis in fructose-fed rats.
    Li S; Li X; Fan J; Jia X; Wang H; Dong F; Mao H; Zhang C; Wang W; Jiang Y; Yan L; Zhang N
    J Nat Med; 2022 Sep; 76(4):765-773. PubMed ID: 35534765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker-based Inflammatory Score in Obese Patients with Resistant Hypertension.
    Rodrigues CIS
    Arq Bras Cardiol; 2019 Apr; 112(4):390-391. PubMed ID: 30994716
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects.
    Catharina AS; Modolo R; Ritter AMV; Sabbatini AR; Lopes HF; Moreno Junior H; Faria AP
    Arq Bras Cardiol; 2018 Jun; 110(6):514-521. PubMed ID: 30226908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waist-hip ratio as a predictor of myocardial infarction risk: A systematic review and meta-analysis.
    Cao Q; Yu S; Xiong W; Li Y; Li H; Li J; Li F
    Medicine (Baltimore); 2018 Jul; 97(30):e11639. PubMed ID: 30045310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant Hypertension and Sleep Duration among Blacks with Metabolic Syndrome MetSO.
    Rogers A; Necola O; Sexias A; Luka A; Newsome V; Williams S; McFarlane SI; Jean-Louis G
    J Sleep Disord Treat Care; 2016; 5(4):. PubMed ID: 28066790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagus Nerve Stimulation Improves Cardiac Function by Preventing Mitochondrial Dysfunction in Obese-Insulin Resistant Rats.
    Samniang B; Shinlapawittayatorn K; Chunchai T; Pongkan W; Kumfu S; Chattipakorn SC; KenKnight BH; Chattipakorn N
    Sci Rep; 2016 Feb; 6():19749. PubMed ID: 26830020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in hypertensive patients: An unholy alliance.
    Mulè G; Calcaterra I; Nardi E; Cerasola G; Cottone S
    World J Cardiol; 2014 Sep; 6(9):890-907. PubMed ID: 25276291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to the etiology of metabolic syndrome.
    Muñoz Contreras AM; Bedoya Berrío G; Velásquez R CM
    Colomb Med (Cali); 2013 Jan; 44(1):57-63. PubMed ID: 24892324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.
    Canale MP; Manca di Villahermosa S; Martino G; Rovella V; Noce A; De Lorenzo A; Di Daniele N
    Int J Endocrinol; 2013; 2013():865965. PubMed ID: 24288531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and insulin resistance in resistant hypertension: implications for the kidney.
    Rao A; Pandya V; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine abnormalities in the etiology of the cardiometabolic syndrome.
    DeMarco VG; Johnson MS; Whaley-Connell AT; Sowers JR
    Curr Hypertens Rep; 2010 Apr; 12(2):93-8. PubMed ID: 20424939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and the cardiometabolic syndrome.
    Manrique C; Lastra G; Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2005 Aug; 7(8):471-6. PubMed ID: 16103758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?
    Rodríguez A; Catalán V; Gómez-Ambrosi J; Frühbeck G
    Curr Pharm Des; 2007; 13(21):2169-75. PubMed ID: 17627548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant hypertension in the high-risk metabolic patient.
    Chaudhary K; Buddineni JP; Nistala R; Whaley-Connell A
    Curr Diab Rep; 2011 Feb; 11(1):41-6. PubMed ID: 20941645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between abdominal obesity and the metabolic syndrome.
    Phillips LK; Prins JB
    Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.